
We are pleased to announce the in-person annual meeting of the US Deprescribing Research Network, which will be held in conjunction with the American Geriatrics Society annual meeting in Chicago, IL on May 7, 2025. The USDeN annual meeting is open to all people who are conducting or care about research on deprescribing medications and addressing medication overuse among older adults.
This meeting will comprise a wide-ranging series of sessions and activities that are focused on:
- Enhancing skills, providing multidisciplinary perspectives, and offering practical guidance on and opportunities for deprescribing research
- Communicating how the network can help you and your research interests
- Building collaborations and community among people interested in deprescribing research and how it can be used to improve care for older adults
The meeting will include a poster session. Encore submissions from research submitted for presentation at AGS, the Society of General Internal Medicine, and other meetings are welcome. We will update this page with additional information as it becomes available, including how to submit poster abstracts.
Join us as we build a community of researchers and stakeholders that will generate science, address logistical and safety challenges, and develop infrastructure to promote the conduct and dissemination of research on deprescribing
USDeN 2025 Annual Meeting Agenda
7:30 AM
Registration and Breakfast
8:30 AM
Welcome Address
9:00 AM
Keynote Address: Evidence synthesis, clinical practice guidelines, and research implications for deprescribing safety
Keynote Speaker: Emily Reeve, BPharm(Hons), PhD – Monash University
10:00 AM
Break (with morning snacks)
10:15 AM
Moderated Panel: Deprescribing and Age-Friendly Health Systems
11:15 AM
Updates in Deprescribing Research
12:00 PM
Lunch Break
12:45 PM
USDeN-Sponsored Research: Presentations with panel discussion
1:45 PM
Breakout Groups: Small group discussion based on attendee interest
2:45 PM
Poster Session
4:00 PM
Moderated Panel: Keeping Positive – Learning from Deprescribing Trials
4:45 PM
Closing Remarks